Eruptive milia during isotretinoin therapy

William Farmer; Kyle Cheng; Kalyani Marathe

doi:10.1111/pde.13270

Eruptive milia during isotretinoin therapy

Pediatr Dermatol. 2017 Nov;34(6):728-729. doi: 10.1111/pde.13270. Epub 2017 Sep 21.

Authors

William Farmer¹, Kyle Cheng^{1

2

3

4}, Kalyani Marathe⁴

Affiliations

¹ School of Medicine, Georgetown University, Washington, DC, USA.
² Department of Dermatology, Washington Hospital Center, Washington, DC, USA.
³ Department of Internal Medicine, Washington Hospital Center, Washington, DC, USA.
⁴ Department of Dermatology, Children's National Health System, Washington, DC, USA.

PMID: 28940619
DOI: 10.1111/pde.13270

Abstract

Isotretinoin (13-cis-retinoic acid) is a synthetic vitamin A derivative that is effective in the treatment of recalcitrant, nodulocystic acne. To our knowledge, there are no reports in the medical literature of milia as a side effect of isotretinoin. We report a case of eruptive facial milia in the setting of isotretinoin treatment for acne.

Publication types

Case Reports

MeSH terms

Acne Vulgaris / drug therapy*
Adolescent
Dermatologic Agents / adverse effects*
Dermatologic Agents / therapeutic use
Exanthema / chemically induced*
Humans
Isotretinoin / adverse effects*
Isotretinoin / therapeutic use
Male

Substances

Dermatologic Agents
Isotretinoin